Angry villagers are not ready to concede defeat despite being told an historic footbridge is to be demolished. The steel ...
Incyte Corporation (NASDAQ:INCY) Q4 2025 Earnings Call Transcript February 10, 2026 Incyte Corporation misses on earnings expectations. Reported EPS is $1.46 EPS, expectations were $1.94. Operator: ...
Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to Hold.
In conversation with Amit Baruah, Nidhi Razdan explains how Indian media moved from questioning power to repeating handouts, and why fear, ownership, and weakened institutions now define journalism in ...
Disclosure Austria,” a playful campaign asking tourists to sign a humorous NDA before receiving insider tips from locals - an attempt to reduce overcrowding and spread visitors beyond hotspots.
Hispanic conservatives are sounding the alarm on Abraham Enriquez, accusing the House of Representatives hopeful of defrauding donors and orchestrating a scheme that pulled in hundreds of thousands of ...
A large number of child victims of convicted sex offender Jeffrey Epstein were coerced into participating in trafficking activities once they reached adulthood, tech billionaire Elon Musk claimed on ...
Rahul Gandhi’s aggressive Parliament strategy hasn’t translated into electoral gains. Can street mobilisation beat BJP narrative politics in 2026?
The government is looking at amending DRIPA after a landmark court ruling in December that determined it was legally enforceable and not just symbolic.
India Today on MSN
Can Jamaat pull off a Bihar in Bangladesh polls?
The 'jungle raj' spectre proved potent in the NDA sweep of Bihar. In the Bangladesh national election, the Jamaat-e-Islami is using a similar playbook against the BNP ...
Afghanistan head coach Jonathan Trott said that Afghanistan's poor fielding led to their defeat against South Africa in their second group fixture at the Narendra Modi Stadium in Ahmedabad.
Michael Schmidt Guggenheim Securities, LLC, Research Division. All right. So daraxonrasib, obviously, there's been a lot of focus on the upcoming phase. The first randomized Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results